哈门那医保(Humana)

最新新闻

• RBC Capital Maintains Humana(HUM.US) With Hold Rating, Maintains Target Price $415
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• Barclays Maintains Humana(HUM.US) With Buy Rating, Raises Target Price to $582
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• Baird Upgrades Humana(HUM.US) to Buy Rating, Raises Target Price to $596
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  Barclays Maintains Humana(HUM.US) With Hold Rating, Maintains Target Price $407
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  Barclays Upgrades Humana(HUM.US) to Buy Rating, Raises Target Price to $515
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• 评级变动
  Jefferies Maintains Humana(HUM.US) With Buy Rating, Cuts Target Price to $420
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• Oppenheimer Maintains Humana(HUM.US) With Buy Rating, Raises Target Price to $475
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 公司公告
  Inari Amertron: Notice of Interest Sub. S-hldr (29B) - Tan Lee Pang s/o Hum Beng
  Bursa Malaysia · 2012/7/27
• 评级变动
  Cantor Fitzgerald Upgrades Humana(HUM.US) to Buy Rating, Raises Target Price to $460
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  UBS Maintains Humana(HUM.US) With Hold Rating, Maintains Target Price $405
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• 评级变动
  BofA Securities Maintains Humana(HUM.US) With Buy Rating, Maintains Target Price $500
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  Bernstein Maintains Humana(HUM.US) With Buy Rating, Maintains Target Price $425
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 公司公告
  Inari Amertron: Notice of Interest Sub. S-hldr (29B) - Tan Lee Pang s/o Hum Beng
  Bursa Malaysia · 2013/1/23
• 评级变动
  BofA Securities Maintains Humana(HUM.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• 公司公告
  Inari Amertron: Notice of Interest Sub. S-hldr (29B) - Tan Lee Pang s/o Hum Beng
  Bursa Malaysia · 2012/3/26
• 评级变动
  Analysts Are Bullish on Top NA Stocks: Kestra Medical Technologies Ltd. (KMTS), Humana (HUM)
  TipRanks · 2026/9/15
• 评级变动
  J.P. Morgan Maintains Humana(HUM.US) With Hold Rating, Raises Target Price to $393
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• U.S. Stock Market Movers | Significant Improvement in Medicare Advantage Plan Ratings Drives Humana (HUM.US) Up Nearly 12%
  Zhitong Finance · 2026/10/9
• 公司公告
  Inari Amertron: Notice of Interest Sub. S-hldr (29B) - Tan Lee Pang s/o Hum Beng
  Bursa Malaysia · 2012/2/15
• 评级变动
  Wells Fargo Maintains Humana(HUM.US) With Buy Rating, Maintains Target Price $502
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Jefferies Maintains Humana(HUM.US) With Buy Rating, Raises Target Price to $624
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  Truist Financial Maintains Humana(HUM.US) With Hold Rating, Raises Target Price to $415
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• 评级变动
  A Quick Look at Today's Ratings for Humana(HUM.US), With a Forecast Between $249 to $513
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  A Quick Look at Today's Ratings for Humana(HUM.US), With a Forecast Between $280 to $513
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  Morgan Stanley Upgrades Humana(HUM.US) to Hold Rating, Raises Target Price to $370
  \u5e02\u573a\u8d44\u8baf · 2026/8/5

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。